Clinuvel September Quarter Appendix 4C | One of My Long Term Buy and Holds
Clinuvel September Quarter Appendix 4C | One of My Long Term Buy and Holds
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Clinuvel September Quarter Appendix 4C | One of My Long Term Buy and Holds

Clinuvel September Quarter Appendix 4C | One of My Long Term Buy and Holds

|
Why I Am Excited About Clinuvel | FY21 Results and June Quarter Appendix 4C

Why I Am Excited About Clinuvel | FY21 Results and June Quarter Appendix 4C

|
Stock of the Day: Clinuvel Pharmaceuticals (#CUV)

Stock of the Day: Clinuvel Pharmaceuticals (#CUV)

|
Genetic Signatures September Quarter Appendix 4C | OPCF Positive $3m

Genetic Signatures September Quarter Appendix 4C | OPCF Positive $3m

|
What Caused Clinuvel Share Price to Drop 20% in Two Days on ZERO Negative News From the Company

What Caused Clinuvel Share Price to Drop 20% in Two Days on ZERO Negative News From the Company

|
Clinuvel Scenesse Phillip Wolgen

Clinuvel Scenesse Phillip Wolgen

|
CLINUVEL at Morgans Scone Value in the Vines Investor Conference 2021

CLINUVEL at Morgans Scone Value in the Vines Investor Conference 2021

|
Xref June Quarter Appendix 4C | Sensational Results

Xref June Quarter Appendix 4C | Sensational Results

|
CLINUVEL Investor Webinar

CLINUVEL Investor Webinar

|
Clinuvel Pharmaceuticals Aktienanalyse (CLVLY)

Clinuvel Pharmaceuticals Aktienanalyse (CLVLY)

|
hipages FY21 Results and June Quarter Appendix 4C |

hipages FY21 Results and June Quarter Appendix 4C |

|
Insider Insights II: Willem Blijdorp, CLINUVEL’s Products, People & Social Purpose

Insider Insights II: Willem Blijdorp, CLINUVEL’s Products, People & Social Purpose

|
CLINUVEL - What is a Stroke?

CLINUVEL - What is a Stroke?

|
CLINUVEL AGM - 2021

CLINUVEL AGM - 2021

|
My Process | What I Do On The Equal Busiest Day of the Year

My Process | What I Do On The Equal Busiest Day of the Year

|
Pointsbet Share Price Down 25% Is It Time to Buy? | September Quarter Appendix 4C

Pointsbet Share Price Down 25% Is It Time to Buy? | September Quarter Appendix 4C

|
Has MedAdvisor Hit an Inflection Point? | OPCF + by $2m on Significant Increase in Receipts

Has MedAdvisor Hit an Inflection Point? | OPCF + by $2m on Significant Increase in Receipts

|
Why Clinuvel Is Taking a Dual Focus Approach on Pharmaceuticals and Cosmetics

Why Clinuvel Is Taking a Dual Focus Approach on Pharmaceuticals and Cosmetics

|
13% and 20% versus 2%!! SMASHING the Market!! | October (Four Months) Portfolios Update

13% and 20% versus 2%!! SMASHING the Market!! | October (Four Months) Portfolios Update

|
The Power of Compounding & Why I Invest in Growth Companies | Stock Fight: Telstra vs CSL

The Power of Compounding & Why I Invest in Growth Companies | Stock Fight: Telstra vs CSL

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa